BioTech Medics' (BMCS) goal is to have 100 or more BioTech Laser™ Centers operating nationwide, similar to the 80 Lasik-Plus Eye Vision Centers operating. BioTech has finalized a strategic franchise alliance that will put BioTech on the fast-track.
BioTech Medics (BMCS) has developed proprietary pain management protocols utilizing patented FDA 510(k) cleared high powered deep penetrating medical therapeutic lasers for reducing or eliminating muscular, skeletal, nerve and/or arthritic pain over the entire body. The procedures are drug-free, quick (15 to 30 minutes) safe and non-invasive. BioTech has affiliated centers operating in Dallas, Kansas City (Overland Park), Albuquerque and Santa Fe, NM. A new center is pending in Newport Beach.
BioTech's advantage over competition is their proprietary protocols for the high-powered therapeutic medical lasers that the patient feels healing their body. Most competitors use "cold lasers" that operate with 5,000 to 12,000 times less power. Patients cannot feel a cold laser. Back pain, carpal tunnel, shoulder, knees and hip pain are treated in each center.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com has been compensated three thousand five hundred dollars by a third party Green Horseshoe for its efforts in profiling BioTech Medics.